Codes / ICD10CM / Z16.30

Z16.30 Resistance to unspecified antimicrobial drugs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Resistance to unspecified antimicrobial drugs (ICD-10-CM Code: Z16.30)

Summary

Resistance to unspecified antimicrobial drugs is a condition where bacteria develop the ability to withstand the effects of antimicrobial agents not classified under specific resistance categories. This resistance can limit treatment options for infections, as affected bacteria may no longer respond to standard therapies.

Causes

The primary cause is genetic changes in bacteria that reduce antimicrobial effectiveness. These changes may include enzyme production that inactivates drugs, altered drug targets, or reduced drug uptake. Resistance can develop due to selective pressure from antimicrobial use or horizontal gene transfer between bacteria.

Risk Factors

  • Previous or prolonged use of multiple antimicrobial classes.
  • Hospitalization, particularly in intensive care units.
  • Weakened immune system from underlying conditions or treatments.
  • Presence of invasive medical devices (e.g., catheters, ventilators).
  • Exposure to healthcare environments with high resistance rates.

Symptoms

Resistance itself does not cause symptoms, but infections with resistant bacteria may present typical infection signs such as fever, pain, swelling, or discharge at the infection site, depending on the affected area.

Diagnosis

Diagnosis involves laboratory testing, including antimicrobial susceptibility testing, to identify resistance patterns. Clinical evaluation of infection symptoms and patient history of antimicrobial use may also guide diagnosis.

Treatment Options

Treatment focuses on selecting alternative antimicrobial agents based on susceptibility results. In some cases, combination therapy or higher doses may be necessary. Supportive care, such as managing infection symptoms, is also important.

Prognosis and Follow-Up

Prognosis depends on the type of infection, the extent of resistance, and the patient’s overall health. Follow-up may involve repeat testing to monitor resistance and adjust treatment as needed. Close monitoring for treatment response is essential.

Complications

Complications can include prolonged or severe infections, increased risk of treatment failure, and potential spread of resistant bacteria to others. In severe cases, resistant infections may lead to sepsis or organ damage.

Lifestyle & Prevention

  • Use antimicrobials only as prescribed and complete the full course of treatment.
  • Practice good hygiene, such as handwashing, to reduce infection risk.
  • Avoid unnecessary antimicrobial use, especially for viral infections.
  • Stay up-to-date with vaccinations to prevent infections.

When to Seek Professional Help

Seek medical attention if infection symptoms worsen or do not improve with treatment, or if new symptoms (e.g., high fever, severe pain) develop. Prompt evaluation is important for resistant infections.

Tips for Medical Coders

Document the specific antimicrobial resistance when known. If unspecified, use Z16.30. Ensure documentation supports the resistance diagnosis and aligns with clinical findings.

Book a walkthrough

Z16.30 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.